Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about VentyxBiosciences-2021-10-20
$174.3 Million
Image
Ventyx Biosciences
Initial Public Offering
Active Bookrunner
Read more
about Nuvalent-2021-07-28
$190.6 Million
Image
Nuvalent
Initial Public Offering
Active Bookrunner
Read more
about MonteRosaTherapeutics-2021-06-23
$255.0 Million
Image
Monte Rosa Therapeutics
Initial Public Offering
Active Bookrunner
Read more
about PriviaHealthGroupInc-2021-04-28
$515.7 Million
Image
Privia Health Group, Inc.
Initial Public Offering
Active Bookrunner
Read more
about MinervaSurgicalInc-2021-10-21
$75.0 Million
Image
Minerva Surgical Inc.
Initial Public Offering
Active Bookrunner
Read more
about DayOneBiopharmaceuticalsInc-2021-05-26
$184.0 Million
Image
Day One Biopharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
Read more
about CVRxInc-2021-06-29
$144.9 Million
Image
CVRx, Inc.
Initial Public Offering
Active Bookrunner
Read more
about CenturyTherapeuticsInc-2021-06-17
$242.0 Million
Image
Century Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
Read more
about BiomeaFusion-2021-04-15
$176.0 Million
Image
Biomea Fusion
Initial Public Offering
Active Bookrunner
Read more
about CytekBiosciencesInc-2021-07-22
$284.7 Million
Image
Cytek Biosciences, Inc.
Initial Public Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 12
Next page
››
Subscribe to Active Bookrunner